Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03069716 · ClinicalTrials.gov registry record · NA
A Mobile Health Intervention in Pulmonary Arterial Hypertension
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT03069716 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 49 participants.
The verdict
NCT03069716, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
This study proposes the use of a mobile health intervention (utilizing a smart phone app) to encourage increased exercise in PAH patients. The study will be a randomized trial to examine feasibility of an mHealth (mobile device) Fitbit Charge HR and cell phone application intervention to improve step counts and increase participants activity level as compared to no intervention. The Fitbit Charge Heart Rate (HR) monitors activity and the cell phone application provides encouragement notifications to half the subjects while the other half do not receive encouragements.
Interventions
- DEVICE Smartphone Text Messaging
- DEVICE Fitbit Charge HR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2017-08-02 |
| Est. Completion | 2020-04-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03069716
The ClinicalTrials.gov registry entry for NCT03069716 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Smartphone Text Messaging is the first listed.
NCT03069716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03069716 about?
NCT03069716 is a clinical study titled "A Mobile Health Intervention in Pulmonary Arterial Hypertension". This study proposes the use of a mobile health intervention (utilizing a smart phone app) to encourage increased exercise in PAH patients. The study will be a randomized trial to examine feasibility of an mHealth (mobile device) Fitbit Charge HR and cell phone application intervention to improve ste...
What is the current status of trial NCT03069716?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2017-08-02. Estimated completion is 2020-04-24.
What interventions are being tested in trial NCT03069716?
The interventions under investigation include: Smartphone Text Messaging (DEVICE), Fitbit Charge HR (DEVICE).
Who is sponsoring clinical trial NCT03069716?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.